Clinuvel Pharmaceuticals Limited (OTCMKTS:CLVLY) Short Interest Update

Clinuvel Pharmaceuticals Limited (OTCMKTS:CLVLY) was the target of a large increase in short interest in the month of January. As of January 31st, there was short interest totalling 11,000 shares, an increase of 46.7% from the January 15th total of 7,500 shares. Based on an average daily trading volume, of 2,200 shares, the days-to-cover ratio is currently 5.0 days.

Clinuvel Pharmaceuticals Price Performance

Shares of Clinuvel Pharmaceuticals stock opened at $7.30 on Friday. Clinuvel Pharmaceuticals has a 52 week low of $6.80 and a 52 week high of $11.40. The business has a 50 day moving average price of $7.58 and a 200-day moving average price of $8.75.

About Clinuvel Pharmaceuticals

Clinuvel Pharmaceuticals Limited, a biopharmaceutical company, focuses on developing and commercializing treatments for patients with genetic, metabolic, and life-threatening disorders in Australia, Europe, the United States, Switzerland, and internationally. Its lead drug candidate is SCENESSE, a systemic photoprotective drug for the prevention of phototoxicity in adult patients with erythropoietic protoporphyria (EPP).